Sonorous Neurovascular, a developer of solutions for cerebral venous diseases and neurovascular interventions, announced that ...

Efemoral Medical announced long-term results of the first 40 patients treated in the EFEMORAL I first-in-human (FIH) clinical ...

Boston Scientific announced an analysis of 989 patients with hepatocellular carcinoma (HCC) from the PROACTIF prospective real-wo ...

Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluat ...

Gore & Associates announced that its Excluder thoracoabdominal branch endoprosthesis (TAMBE) received CE Mark approval earlie ...

A man in his early 60s with prior carotid endarterectomy (CEA) followed by interposition common carotid artery ...

Experience at a large, urban academic institution with a focus on comprehensive clinical practice, multidisciplinary ...

In experienced hands, hybrid radial-pedal access techniques represent a practical alternative to femoral access for selected ...

Translating the 2026 PE guideline recommendations into practice to enhance decision-making, streamline care pathways, and ...

Adopting next-generation technologies can help centers stay at the cutting edge of innovative care. However, the burden of ...

We spoke with three Principal Investigators (PIs) from the AAA-SHAPE pivotal trial—Dr. Linda Harris, Dr. Caitlin Hicks, and ...

Exploring the role of hypertension centers of excellence, referral pathways, strategies to optimize care for resistant ...